Inside the triple helix: technology transfer and commercialization in the life sciences.
The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities. Future efforts with regard to technology transfer in the life sciences will need to recognize its importance without ignoring concerns or overestimating benefits. Next steps include better monitoring of university-industry relationships, the development of a better data system, the dissemination of best practices in technology transfer management, and evaluation of national technology-transfer policies.
Harvard Medical School, USA.
Eric G
EG
Campbell
Joshua B
JB
Powers
David
D
Blumenthal
Brian
B
Biles
D001690:Biological Science Disciplines; D003132:Commerce; D009316:National Institutes of Health (U.S.) / Q000191:economics; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D012106:Research; D018581:Technology Transfer; D014481:United States